Class Actions Against Chinese Firms Likely

A new wave of class-action lawsuits arising from two recalled drugs , generic blood thinner heparin and prescription medication Digitek could lead attorneys into new legal and geographic territory. Attorneys involved in the cases say new defective-product claims may bypass federal pre-emption defenses and could lead to suits against manufacturers linked to China. However, not all attorneys anticipate such a smooth road for such litigation. Amanda Bronstad, Law.com 07/24/2008
Read Article